PORTEFEUILLE

Viral or bacterial infections and anaemia are conditions which usually require a doctor’s visit. To help diagnose these conditions, trained medical personnel perform complete blood count analysis using expensive flowcytometric lab equipment. Our new product “Microcyte” aims to reduce these high lab investment costs. We are developing a pocket-sized haematology device that makes a low-cost complete blood cell count possible. With an innovative image-based microfluidic flow cytometric approach, our solution makes blood cell analysis at people’s home feasible. Thus, mobile doctor or nursing staff working in the fast-growing home-care health sector could be equipped with our diagnostic point-of-care (PoC) device as well as medical-scarce regions that do not have access to hospitals/doctor' surgeries.

The provided funding by the Gebert Rüf Stiftung enables the further implementation of the project "Microcyte. Currently, we are improving the technology for image processing and the optical setup of the diagnostic device to meet the criteria for later certification. Furthermore, our first prototype shall be enhanced according to the customer's needs and the requirements for a CE mark and FDA approval. The new funding of the BRIDGE Proof of Concept program has secured funding for 2025.